Stonehearth Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,679
Closed -$250K 73
2022
Q4
$250K Buy
2,679
+9
+0.3% +$868 0.14% 55
2022
Q3
$255K Sell
2,670
-38
-1% -$3.76K 0.16% 48
2022
Q2
$255K Buy
2,708
+40
+1% +$3.9K 0.15% 52
2022
Q1
$270K Sell
2,668
-841
-24% -$88.3K 0.14% 55
2021
Q4
$362K Sell
3,509
-11
-0.3% -$1.02K 0.19% 41
2021
Q3
$299K Buy
3,520
+51
+1% +$4.27K 0.16% 48
2021
Q2
$289K Buy
3,469
+587
+20% +$48.1K 0.14% 51
2021
Q1
$217K Buy
+2,882
New +$210K 0.12% 61

Other funds holding CVS

Stonehearth Capital Management's CVS Position: Q1 2023 in Review

Stonehearth Capital Management sold out of CVS Health (CVS) in Q1 2023, closing a stake of 2,679 shares — an estimated $250K sold.

Stonehearth Capital Management first reported a position in CVS in Q1 2021 and held it in 8 quarters. The position peaked at $362K in Q4 2021. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Stonehearth Capital Management reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • Stonehearth Capital Management sold 2,679 CVS Health shares in Q1 2023, an estimated $250K.
  • Stonehearth Capital Management first reported a position in CVS Health in Q1 2021 and held it in 8 quarters.
  • Stonehearth Capital Management's CVS Health position peaked at $362K in Q4 2021.
  • 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Stonehearth Capital Management's 13F filing for Q1 2023, filed 4 Apr 2023.